DA
BSX icon

Duality Advisers’s Boston Scientific BSX Stock Holding History

Duality Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,383
Closed -$760K – 549
2022
Q2 		$760K Sell
20,383
-4,116
-17% -$168K 0.07% 409
2022
Q1 		$1.08M Buy
+24,499
New +$1.06M 0.12% 303
2020
Q4 		– Sell
-164,580
Closed -$6.29M – 565
2020
Q3 		$6.29M Sell
164,580
-17,962
-10% -$692K 0.4% 50
2020
Q2 		$6.41M Buy
+182,542
New +$6.57M 0.58% 35
2019
Q2 		– Sell
-126,800
Closed -$4.87M – 233
2019
Q1 		$4.87M Buy
+126,800
New +$4.84M 0.29% 106

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Duality Advisers's BSX Position: Q3 2022 in Review

Duality Advisers sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 20,383 shares — an estimated $760K sold.

Duality Advisers first reported a position in BSX in Q1 2019 and held it in 5 quarters. The position peaked at $6.41M in Q2 2020. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Duality Advisers reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
  • Duality Advisers sold 20,383 Boston Scientific shares in Q3 2022, an estimated $760K.
  • Duality Advisers first reported a position in Boston Scientific in Q1 2019 and held it in 5 quarters.
  • Duality Advisers's Boston Scientific position peaked at $6.41M in Q2 2020.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Duality Advisers's 13F filing for Q3 2022, filed 3 Nov 2022.